Tamar Kfir

Maayan Ventures Ltd. is a technological incubator investing in early stage start-up companies. It specializes in developing early stage high-tech ventures in fields, such as medical devices, materials, homeland security, cleantech, IT and communication and water. The firm also specializes in establishing, branding and marketing new technological innovations. It holds shares in Capital Point - a publicly traded company on the TASE owning 2 peripheral incubators in Ofakim and Katzrin. The company was founded in 1990 and is headquartered in Herzliya, Israel.

ProtAb Ltd. develops drug treatment for rheumatoid arthritis. It develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune inflammatory diseases. The company was Founded by Yaakov Naparstek in 2005 and is headquartered in Jerusalem, Israel.

BotanoCap Ltd. operates as a green product development company. The firm’s products include background, post-harvesting, pre-harvesting and rooting stimulants. The company was founded by Charles Linder and Arie Markus in 2004 and is headquartered in Ramat Gan, Israel.

Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel.

Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel.

Ten - Petroleum Co. Ltd. markets and supplies fuel through gas stations. It operates convenience stores as an integral part of operations. The firm builds gas stations in close proximity to business, commercial and industrial areas and maintains contact between all its stations. The company was founded in 1991 and is headquartered in Netaniya, Israel.

Psagot Investment House Ltd. engages in the management of assets for individuals, businesses, and institutional investors. Its products include retirement savings, provident funds, education funds, pension funds, and exchange-traded notes. The company was founded in 1963 and is headquartered in Tel Aviv, Israel.